Eledon Pharmaceuticals, Inc.
https://eledon.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Eledon Pharmaceuticals, Inc.
Deal Watch: Bausch Health Takes Option To Allegro Dry AMD Candidate
Bausch seeks to add eyecare assets in Allegro deal. AstraZeneca hopes preclinical PCSK9 inhibitor from Dogma can compete with dyslipidemia leaders. Exelixis options ADC candidates from Catalent and NBE.
Appointments: New CEOs For Lundbeck, Voyager & Neos, CSOs For iTeos & Tilos
Deborah Dunsire’s appointment to lead Lundbeck tops this week’s list of new hires; Astellas, Orchard Therapeutics, Voyager Therapeutics, iTeos Therapeutics, Cevec Pharmaceuticals, Sangamo Therapeutics, Cedilla Therapeutics, Tilos Therepautics and Neos Therapeutics have also appointed new executives and directors.
Venture Funding Deals: Two Companies With China Ties Raise $260m Each
Suzhou-based immuno-oncology specialist CStone raised a $260m Series B round and Brii launched with $260m in Series A cash to develop drugs for the China market. Also, multiple start-ups launched recently with more than $50m in Series A rounds, including Ansun, Beam, Casma, Celsius and Neurana.
Appointments: Flex Pharma, Bicycle Therapeutics, Nordic Nanovector, Biogen, CRISPR and NightstaRx
The week's roundup includes the appointment of a new CEO by Flex Pharma and various other high-level appointments by Bicycle Therapeutics, SetPoint Medical, Theravance Biopharma and Nordic Nanovector.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Anelixis Therapeutics, Inc., Apple Tree Partners, OticPharma, Otic Pharma, Ltd., Tokai Pharmaceuticals, Inc., Novus Therapeutics, Inc.